Norgreen
Norgreen S.A. is an Argentine pharmaceutical manufacturer founded in 1995 that produces generic injectable medicines — small and large volume parenterals plus sterile powders — for Argentine public and private hospitals via government tenders and direct sales.
- Company typePrivate
- Founded1995
- HeadquartersMar del Plata, Argentina
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What Norgreen does
Norgreen S.A. is an Argentine pharmaceutical manufacturer founded in 1995 by Dr. Rodolfo Aníbal Foglia and headquartered in the General Savio Industrial Park of Mar del Plata, Buenos Aires Province. The company produces generic injectable medicines for hospital use, operating three GMP-compliant production plants across small volume parenterals (ampoules and vials 1-20 ml), large volume parenterals (semi-rigid and flexible polypropylene sachets 100-500 ml), and sterile powders (vials 10-30 ml). It also runs an integrated glass packaging manufacturing facility with three Moderne Mecanique MM30 lines, producing roughly 4 million ampoules and 720,000 vials per month to feed its own primary container demand — a vertical integration that gives the firm traceability from glass container fabrication through finished product distribution.
The company's product portfolio spans more than 50 medicinal products, including antibiotics, analgesics, anesthetics, and parenteral solutions, with combined monthly capacity of approximately 4-4.5 million ampoules, 1 million sachets, and 600,000 sterile powder vials. Manufacturing relies on continuous production lines for washing, depyrogenation, filling, terminal autoclave sterilization, automatic inspection, and packaging, with strict aseptic protocols to meet pharmaceutical GMP standards.
Commercially, Norgreen operates a sales-led B2B model targeting Argentine public and private healthcare institutions. Distribution is conducted exclusively through government procurement tenders (licitaciones) for the public segment and direct commercial relationships for private hospitals. The firm is privately held with no external institutional investors, no public listing, and no disclosed funding rounds; current leadership includes President Luis Emilio Terry Artusa, who joined as shareholder in 1998. Operations remain confined to Argentina, with multilingual website presence (Spanish, English, French) the only signal of broader geographic intent.
Norgreen firmographics
Firmographics- Name
- Norgreen
- Legal name
- Norgreen S.A.
- Website
- https://norgreen.com
- Company type
- Private
- Founded year
- 1995
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Norgreen S.A. is an Argentine pharmaceutical manufacturer founded in 1995 that produces generic injectable medicines — small and large volume parenterals plus sterile powders — for Argentine public and private hospitals via government tenders and direct sales.
- Ownership category
- akta.pro rank
Norgreen industry classification
Industry- Product category
- Pharmaceutical Manufacturing
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Sterile Injectable Generics (HLAIABAC)
- akta.pro secondary industries
- Sterile & Aseptic Medical Packaging (Pouches, Wraps, Sterile Barriers) (IMALAIAB), Primary Pharmaceutical Packaging (Blister Packs, Bottles, Vials, Ampoules) (IMALAIAA), Parenteral & Injectable Packaging Components (Stoppers, Seals, Syringes, Cartridges) (IMALAIAE)
Keywords
Where Norgreen is headquartered
LocationHeadquarters
- HQ city
- Mar del Plata
- HQ country
- Argentina
- HQ region
- Latin America
Offices1 record
Markets served
Norgreen business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Supply Chain, Personnel, Technology or R&D, Marketing or Sales
Revenue model
- Pharmaceutical Product Sales: Norgreen manufactures and commercializes generic pharmaceutical products including injectable solutions, sterile powders, antibiotics, analgesics, and anesthetics. Revenue is generated through direct sales and procurement tenders to public and private healthcare institutions across Argentina.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels6 records
Norgreen product offering
Product offeringCore offering
Norgreen manufactures generic injectable pharmaceutical products including small volume parenterals (ampoules and vials of 1-20 ml), large volume parenterals (semi-rigid and flexible polypropylene sachets of 100-500 ml), and sterile powders (vials of 10-30 ml). The company operates three GMP-compliant production plants and an integrated glass packaging manufacturing facility in Mar del Plata, Argentina, producing more than 50 medicinal products supplied to public and private healthcare institutions through procurement tenders and direct sales.
Product overview
Norgreen is a pharmaceutical manufacturer specializing in generic injectable medicines. The company operates three production plants in Mar del Plata, Argentina, using five modern production lines to manufacture over 50 medicinal products. The product portfolio consists of three main categories: Small Volume Parenterals (ampoules and vials 1-20 ml), Large Volume Parenterals (polypropylene sachets 100-500 ml), and Sterile Powders (vials 10-30 ml). The company also operates its own glass packaging manufacturing plant to ensure traceability from primary container production through final product distribution. Products are supplied to public and private healthcare institutions nationwide through procurement tenders and direct sales.
Differentiator
Problem solved
Functional benefit
Products and services
- Small Volume Parenterals Injectable pharmaceutical solutions packaged in ampoules and vials of 1 to 20 ml, produced via continuous production lines including washing, depyrogenation, filling, terminal autoclave sterilization, and automatic inspection. Intended for hospital healthcare institutions across Argentina.
- Large Volume Parenterals Injectable pharmaceutical solutions packaged in semi-rigid and flexible polypropylene sachets of 100 to 500 ml, with terminal autoclave sterilization and manual inspection. Intended for hospital healthcare institutions.
- Sterile Powders Sterile pharmaceutical powders filled into vials of 10, 15, 20, 25, and 30 ml capacity, processed through washing, depyrogenation, powder filling, manual inspection, and packaging. Supplied to hospital healthcare institutions.
Quantifiable outcome
- Maintains traceability from glass container fabrication to finished pharmaceutical product distribution
- +1 more outcomes
Companies that use Norgreen
Customer profileNamed customers2 records
Segments2 records
Ideal customer profiles2 records
Norgreen technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Norgreen partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered leadership, foundational and minor.
- Luis Emilio Terry ArtusaleadershipJoined Norgreen as President and shareholder in late 1998, bringing a comprehensive vision for the organization and driving innovation and growth. His leadership marked a new phase of expansion and market development for the company.
- Dr. Rodolfo Aníbal FogliafoundationalFounder of Norgreen S.A. in 1995. Dr. Foglia established the company as a leader in injectable pharmaceutical products in the Industrial Park of Mar del Plata, Province of Buenos Aires. His initiative founded the company's operations and core mission of providing pharmaceutical products with responsibility and commitment.
- Fundación ConinminorNon-profit foundation collaborating with Norgreen in the fight against child malnutrition. Norgreen supports the foundation's initiatives as part of its corporate social responsibility program.
- Hospital Materno Infantil via FUNDAMIminorNorgreen acts as benefactor to the Maternal and Child Hospital of Mar del Plata through the FUNDAMI organization, supporting maternal and child healthcare in the local community.
- Club Universitario Mar del PlataminorNorgreen supports local sports development through this Mar del Plata-based club, contributing to community engagement and youth development programs.
Scale indicators7 records
Recent moves1 record
Expansion highlights4 records
Norgreen competitors and assessment
Company assessmentDirect peers
- Laboratorios Bagó: One of the largest Argentine pharmaceutical companies with a broad generics portfolio including sterile injectables, and significant public and private hospital sales. Comparable on portfolio breadth and channel access, though materially larger.
- Laboratorio Tuteur: Argentine specialty pharmaceutical manufacturer focused on injectable and sterile products for hospital use. Closely comparable on product format (sterile injectables), institutional GTM, and Argentine domestic focus.
- Laboratorios Richmond: Major Argentine generic pharmaceutical manufacturer with strong institutional/hospital channel presence and a broad portfolio including injectables. Directly comparable as a domestic Argentine generics producer serving public and private healthcare institutions via tenders.
- Laboratorio LIA: Argentine pharmaceutical laboratory producing injectable and sterile products for the hospital channel. Comparable on sterile injectable manufacturing, GMP compliance, and Argentine institutional sales model.
- Laboratorio Pablo Cassará: Argentine manufacturer specializing in sterile injectable pharmaceutical products for the hospital and institutional market. Directly comparable product category (sterile injectables), regulatory profile, and Argentine institutional GTM.
- Cristália: Brazilian pharmaceutical manufacturer specializing in sterile injectables, anesthetics, and hospital-use products with integrated production. Comparable on sterile injectable focus, GMP manufacturing scale, and hospital/institutional channel model across LatAm.
- Laboratorios Beta: Argentine pharmaceutical company with hospital-channel injectable generics and similar GMP-certified manufacturing footprint. Comparable product mix and institutional sales model within the same domestic market.
Others
Broad incumbents
- Eurofarma Laboratórios: Major Brazilian/LatAm generics and injectable pharmaceutical producer with broad hospital portfolio across multiple countries. Comparable on injectable generics and LatAm institutional presence, though with significantly broader geographic and therapeutic scope.
- Teva Pharmaceutical Industries: World's largest generic pharmaceutical manufacturer with extensive sterile injectable portfolio. Comparable product category (sterile injectable generics) and global tender participation; competes with Norgreen on commoditized molecules in institutional tenders.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Norgreen social profiles
Digital presenceNorgreen compliance and trust
Trust signalCompliance1 record
Norgreen financial estimates
Financial estimateRevenue estimate
Valuation estimate
Norgreen leadership team
Management profileNumber of profiles
Profiles2 records
Norgreen funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Norgreen M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Norgreen
What does Norgreen do?
Norgreen manufactures generic injectable pharmaceutical products including small volume parenterals (ampoules and vials of 1-20 ml), large volume parenterals (semi-rigid and flexible polypropylene sachets of 100-500 ml), and sterile powders (vials of 10-30 ml). The company operates three GMP-compliant production plants and an integrated glass packaging manufacturing facility in Mar del Plata, Argentina, producing more than 50 medicinal products supplied to public and private healthcare institutions through procurement tenders and direct sales.
Is Norgreen a public or private company?
Norgreen is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Norgreen founded?
Norgreen was founded in 1995. It employs 51 to 100 people.
Where is Norgreen based?
Norgreen is headquartered in Mar del Plata, Argentina, in the Latin America region.
How does Norgreen make money?
One revenue line is on record: pharmaceutical Product Sales.
Who are Norgreen's main competitors?
Direct peers on record are Laboratorios Bagó, Laboratorio Tuteur, Laboratorios Richmond, Laboratorio LIA, Laboratorio Pablo Cassará, Cristália and Laboratorios Beta. Hikma Pharmaceuticals is listed as an others. Broad incumbents are Eurofarma Laboratórios and Teva Pharmaceutical Industries.
Does Norgreen have an API?
No public API is recorded for Norgreen.
What industry is Norgreen in?
Norgreen's product category is Pharmaceutical Manufacturing. Its primary akta.pro industry code is HLAIABAC, Sterile Injectable Generics, with a secondary code of IMALAIAB, Sterile & Aseptic Medical Packaging (Pouches, Wraps, Sterile Barriers). Its NAICS code is 325412 and its SIC code is 2834.